OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Digitalization of bioprocessing is slowly bringing benefits to the biopharma industry.
Pharma companies set goals and adopt more sustainable alternatives.
BFS technology can help maintain sterility during the biologics manufacturing process.
December 02, 2022
Manufacturing biopharmaceuticals in an aging facility may create quality issues such as equipment breakdown and contamination risks.
The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.
December 01, 2022
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.
November 30, 2022
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 16, 2022
Webinar Date/Time: Wed, Dec 7, 2022 11:00 AM EST
November 15, 2022
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.
In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.